Use of low dose polyethylene glycol solutions in the treatment of functional constipation
- PMID: 10726228
Use of low dose polyethylene glycol solutions in the treatment of functional constipation
Abstract
A brief review is made of trials which used low doses of polyethylene glycol (13-30 g/day) solutions (125-500 ml/day) in the treatment of chronic functional constipation. Most of these were short-term studies, and confirmed that polyethylene glycol solution increased bowel frequency, improved defaecation and decreased stool consistency. Three studies reported that polyethylene glycol electrolyte solution accelerated transit through the large bowel. One long-term study observed remission of constipation-related symptoms in more than 70% of the polyethylene glycol electrolyte solution treated patients, and the efficacy of the treatment was maintained over a 6-month period, despite progressive reduction of daily dosage.
Similar articles
-
Use of polyethylene glycol solution in slow transit constipation.Ital J Gastroenterol Hepatol. 1999 Nov;31 Suppl 3:S255-6. Ital J Gastroenterol Hepatol. 1999. PMID: 10726231 Clinical Trial.
-
Mechanisms of action of low doses of polyethylene glycol in the treatment of functional constipation.Ital J Gastroenterol Hepatol. 1999 Nov;31 Suppl 3:S242-4. Ital J Gastroenterol Hepatol. 1999. PMID: 10726227
-
Use of polyethylene glycol solution in functional and organic constipation in children.Ital J Gastroenterol Hepatol. 1999 Nov;31 Suppl 3:S260-3. Ital J Gastroenterol Hepatol. 1999. PMID: 10726233 Review.
-
Polyethylene glycol solution in subgroups of chronic constipation patients: experience in obstructed defaecation.Ital J Gastroenterol Hepatol. 1999 Nov;31 Suppl 3:S257-9. Ital J Gastroenterol Hepatol. 1999. PMID: 10726232 Clinical Trial.
-
Clinical subgroups of chronic constipation: exploring the potential of polyethylene glycol.Ital J Gastroenterol Hepatol. 1999 Nov;31 Suppl 3:S253-4. Ital J Gastroenterol Hepatol. 1999. PMID: 10726230 Review.
Cited by
-
Polyhexanide-containing solution reduces ciliary beat frequency of human nasal epithelial cells in vitro.Eur Arch Otorhinolaryngol. 2015 Feb;272(2):377-83. doi: 10.1007/s00405-014-3112-5. Epub 2014 Jun 6. Eur Arch Otorhinolaryngol. 2015. PMID: 24902802
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical